News & Blog

News & Blog

  • Blog

    19 July 2018

    Cannabis oil: the facts

    Using cannabis oil as a means to treat or cure cancer is a topic of much online debate and the internet is full of people claiming that it has effectively helped to cure their cancer. We take a closer look at the evidence behind these claims.
    Cannabis oil
  • Blog

    18 July 2018

    Bloating: your questions answered

    People will describe bloating in slightly different ways, but usually, it is the uncomfortable feeling of tightness or distention around the abdomen. It might be accompanied by pain or the increased need to pass wind.
    Bloated
  • Your Stories

    16 July 2018

    Alan Roberts

    Alan Roberts pays tribute to his beloved wife, Carys, who lost her life to ovarian cancer in March this year. A hugely talented artist, the sale of Carys's artwork has left an incredible legacy, helping to raise £25,000 for a number of cancer charities.
    Carys Roberts
  • Blog

    13 July 2018

    In the news: ovarian cancer and talcum powder

    Johnson & Johnson has been ordered to pay £3.6bn in damages to women who claim the company’s baby powder and other talcum powder products caused them to develop ovarian cancer. Our Chief Executive explains why today’s news is no cause for alarm.
    Talcum powder
  • Blog

    10 July 2018

    The sky's the limit: Anika takes the leap for Ovarian Cancer Action

    This month, Anika Roob faced her fears and took part in a skydive for Ovarian Cancer Action. Ovarian cancer has had a devastating effect on Anika's family and she wanted to challenge herself and raise money to help fund research to protect future generations of women.
    Anika skydive
  • News

    10 July 2018

    Allyson Kaye to step down as Chair after 13 years

    After 13 years as Chair of Ovarian Cancer Action, Allyson Kaye MBE has announced her decision to step down. We are delighted that Allyson will continue her close connection with the charity in her new role of President, acting as an advisor and ambassador. Our current Vice-Chair, Dr Wayne Phillips has been appointed in her stead and Allyson will work closely with Wayne and the board as they embark on an exciting new chapter for the charity.
    Allyson Next 10
  • Blog

    04 July 2018

    Celebrating 70 years of the NHS

    The National Health Service turns 70 on 5 July 2018. We wanted to take this opportunity to appreciate the vital role the service plays in the lives of women with ovarian cancer, and to recognise and thank the extraordinary NHS staff – the everyday heroes – who are there to guide, support and care for them, day in, day out.
    NHS
  • Blog

    04 July 2018

    "My story proves how important it is to have an understanding of your family history"

    Jess, 24, discovered she was BRCA2+ after her father was contacted by a relative who had tested positive. She describes the ups-and-downs of the past year, and why she now feels empowered by knowing her genetic status.
    Jess Martin2
  • News

    28 June 2018

    More women could be eligible for groundbreaking ovarian cancer drug

    The Telegraph has reported today that the latest trials of the drug Olaparib (Lynparza) have produced results that could make it accessible for a significantly increased number of women with advanced stage ovarian cancer.
    Young scientist
  • Your Stories

    27 June 2018

    Natasha Cantor

    Natasha has Lynch Syndrome, a genetic mutation which is linked to an increased risk of a number of different cancers. She tells us about her own family history, and why knowing her genetic status has allowed her to feel more in control.
    Natasha Cantor
  • News

    20 June 2018

    Ovarian Cancer Action receives £150,000 at NEX Giving Day

    Ovarian Cancer Action was honoured to have been nominated as one of the six chosen charities for the first NEX Giving Day, held in London on 7th June.
    NEX Giving Day
  • Blog

    18 June 2018

    "Before I was told I was BRCA positive, I had very limited knowledge of what it was"

    Andrea is 40, and mum to three girls. She recently discovered both she and her youngest daughter are BRCA2 positive.
    Andrea Baker
  • News

    15 June 2018

    Ovarian Cancer Action scientists discover mechanism that ‘deactivates’ ovarian cancer cells

    Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells, which could lead to better treatments for women with ovarian cancer.
    Cancer cells
  • Your Stories

    12 June 2018

    Rachel Firmin

    Rachel pushed for genetic testing after losing her mum to breast cancer and discovered that she was BRCA2+. She shares her story.
    Rachel Firmin
  • News

    10 June 2018

    Ovarian Cancer Action launches Hereditary Cancer Risk Tool

    This week sees the launch of Ovarian Cancer Action's Hereditary Cancer Risk Tool, which has been developed to help people identify their cancer risk. We believe everyone has the right to understand if their family history puts them at risk of ovarian and other cancers, as well as the risk-reducing options available.
    Risk tool
  • Blog

    06 June 2018

    "Sarah was very lucky to have been diagnosed in the early stages"

    Andy’s wife Sarah was diagnosed with stage 2 ovarian cancer in 2008. He shares their story to help raise awareness of the importance of early detection and to highlight why an ovarian cancer screening tool is so desperately needed.
    Andy Cheesman
  • News

    01 June 2018

    'Breakthrough' blood test could detect ovarian cancer in its earliest stages

    In today’s news, a blood test has been hailed a ‘possible holy grail’ in the early detection of ovarian cancer. The...
    Blood test
  • News

    01 June 2018

    Ovarian cancer drug Niraparib approved for NHS use

    The National Institute for Health and Care Excellence (NICE) have today announced that a new drug, Niraparib, has been recommended for use in the Cancer Drugs Fund as an option for maintenance treatment of platinum-sensitive relapsed high grade serous epithelial ovarian cancer.
    pills
  • News

    30 May 2018

    What is patient data and how can it help cancer research?

    This month marks a big change in health services as the NHS introduces a new national data opt-out service to give patients more control over how their personal information is used. We take a look at the new system and how data acts as a powerful tool in cancer research.
    Scientist crop
  • News

    22 May 2018

    Artificial intelligence to improve cancer diagnosis

    Ovarian Cancer Action welcomes today’s announcement from the Prime Minister to use emerging technologies to transform cancer diagnosis in the UK, saving around 22,000 lives a year by 2033.
    Diagnosis